Skip to main content
PMC home page
Journal of Medical Toxicology logoLink to Journal of Medical Toxicology
. 2009 Dec;5(4):183–190. doi: 10.1007/BF03178264

A retrospective evaluation of shortened-duration oral N-acetylcysteine for the treatment of acetaminophen poisoning

David P Betten 1,✉, Elizabeth E Burner 2, Stephen C Thomas 3, Christian Tomaszewski 4, Richard F Clark 4
PMCID: PMC3550405  PMID: 19876849

Abstract

Introduction

The use of less than the traditional 72-hour course of oral N-acetylcysteine has been an alternative treatment option following potentially toxic acute and chronic acetaminophen ingestions felt to be at low risk of developing hepatotoxicity. While clinical experience with shortened treatment duration is extensive, there are few studies evaluating the effectiveness and extent to which these regimens may be used.

Methods

A large statewide poison center database was reviewed for all acetaminophen exposures involving potentially toxic acute and chronic ingestions, in addition to those taking place at unknown times. Patients were identified who met laboratory criteria for early N-acetylcysteine (NAC) discontinuation (APAP < 10 μm/mL, INR ≤ 1.3, and AST/ALT ≤ 60 IU) after a minimum of a 140-mg/kg oral NAC loading dose and 5 additional 70-mg/kg doses over 20 hours. A further search of the poison center database was conducted for individuals who received shortened-course (20–48 hours) oral NAC treatment who developed subsequent hepatotoxicity or death.

Results

Of 3303 individuals with potentially toxic acetaminophen ingestions, 1932 met criteria for early NAC discontinuation. Mean treatment duration was 36.4±7.7 hours (acute=37.3±7.6 hours; chronic=34.8±7.4 hours; unknown=35.2±7.6 hours). The poison center database search identified no short-course eligible subjects who developed subsequent hepatotoxicity or death following ≤48 hours of oral NAC.

Conclusion

Treatment with shortened-course oral NAC in patients meeting criteria for early discontinuation may be an effective treatment option in a sizeable proportion of individuals with potentially toxic acetaminophen ingestions.

Keywords: acetaminophen poisoning, N-acetylcysteine, acetaminophen overdose

Full Text

The Full Text of this article is available as a PDF (155.2 KB).

Footnotes

Notes: There was no outside funding of any kind used for this study. The authors have no potential financial conflicts of interest to report.

References

  • 1.Bronstein AC, Spyker DA, Cantilena LR, et al. 2006 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS) Clin Toxicol. 2007;45:815–917. doi: 10.1080/15563650701754763. [DOI] [PubMed] [Google Scholar]
  • 2.Smilkstein MJ, Knapp GL, Fulig KW, et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the National Multicenter Study (1976 to 1985) N Engl J Med. 1988;319:1557–1562. doi: 10.1056/NEJM198812153192401. [DOI] [PubMed] [Google Scholar]
  • 3.Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ. 1991;303:1026–1027. doi: 10.1136/bmj.303.6809.1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.James LP, Farrar HC, Darville RI, et al. Elevation of serum interleukin 8 levels in acetaminophen overdose in children and adolescents. Clin Pharmacol Ther. 2001;70:280–286. doi: 10.1067/mcp.2001.118243. [DOI] [PubMed] [Google Scholar]
  • 5.Auroma OI, Halliwell B, Hoey BM, et al. The antioxidant action of N-acetycysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989;6:593–597. doi: 10.1016/0891-5849(89)90066-X. [DOI] [PubMed] [Google Scholar]
  • 6.Jollow DJ, Mitchell FR, Potter WZ, et al. Acetaminophen-induced hepatic necrosis, II: role of covalent binding in vivo. J Pharmacol Exp Ther. 1973;187:195–202. [PubMed] [Google Scholar]
  • 7.Prescott LF, Illingworth RN, Critchley JA, et al. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ. 1979;2:1097–1100. doi: 10.1136/bmj.2.6198.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Woo OF, Mueller PD, Olson KR, et al. Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose. Ann Emerg Med. 2000;35:363–368. doi: 10.1016/S0196-0644(00)70055-2. [DOI] [PubMed] [Google Scholar]
  • 9.Yip L, Dart RC. A 20-hour treatment for acute acetaminophen overdose. N Engl J Med. 2003;348:2471–2472. doi: 10.1056/NEJM200306123482422. [DOI] [PubMed] [Google Scholar]
  • 10.Tsai CL, Chang ST, Eng TI, et al. A patient-tailored N-acetylcysteine protocol for acute acetaminophen intoxication. Clin Ther. 2005;27:336–341. doi: 10.1016/j.clinthera.2005.03.002. [DOI] [PubMed] [Google Scholar]
  • 11.Betten DP, Cantrell FL, Thomas SC, et al. A prospective evaluation of shortened course oral N-acetylcysteine for the treatment of acute acetaminophen poisoning. Ann Emerg Med. 2007;50:272–279. doi: 10.1016/j.annemergmed.2006.11.010. [DOI] [PubMed] [Google Scholar]
  • 12.Dart RC, Rumack BH. Patient-tailored acetylcysteine administration. Ann Emerg Med. 2007;50:280–281. doi: 10.1016/j.annemergmed.2007.01.015. [DOI] [PubMed] [Google Scholar]
  • 13.Kozer E, McGuigan M. Treatment strategies for early presenting acetaminophen overdose: a survey or medical directors of poison center in North America and Europe. Hum Exp Toxicol. 2002;21:123–127. doi: 10.1191/0960327102ht235oa. [DOI] [PubMed] [Google Scholar]
  • 14.Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol. 2007;25:757–766. doi: 10.1080/01926230701584163. [DOI] [PubMed] [Google Scholar]
  • 15.Singer AJ, Carracio TR, Mofenson HC. The temporal profile of increased transaminase levels in patients with acetaminophen induced liver injury. Ann Emerg Med. 1995;26:49–53. doi: 10.1016/S0196-0644(95)70237-7. [DOI] [PubMed] [Google Scholar]
  • 16.Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol. 2002;40:3–20. doi: 10.1081/CLT-120002882. [DOI] [PubMed] [Google Scholar]
  • 17.Smilkstein MJ, Bronstein AC, Linden C, et al. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med. 1991;20:1058–1063. doi: 10.1016/S0196-0644(05)81352-6. [DOI] [PubMed] [Google Scholar]
  • 18.Sivilotti ML, Yarema MC, Juurlink DN, et al. A risk quantification instrument for acute acetaminophen overdose patients trated with N-acetylcysteine. Ann Emerg Med. 2005;46:263–271. doi: 10.1016/j.annemergmed.2005.04.004. [DOI] [PubMed] [Google Scholar]
  • 19.Buckley NA, Whyte IM, O’Connell DL, et al. Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning? J Toxicol/Clin Toxicol. 1999;37:759–767. doi: 10.1081/clt-100102453. [DOI] [PubMed] [Google Scholar]
  • 20.Parker D, White JP, Paton D, et al. Safety of late acetylcysteine treatment in paracetamol poisoning. Hum Exp Toxicol. 1990;13:25–27. doi: 10.1177/096032719000900106. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Toxicology are provided here courtesy of Springer

RESOURCES